Skip to Content

3D Medicines Inc 01244

Morningstar Rating
HKD 6.03 −0.27 (4.29%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

01244 is trading at a 51% discount.
Price
HKD 6.25
Fair Value
HKD 26.95
Uncertainty
Extreme
1-Star Price
HKD 12.47
5-Star Price
HKD 4.55
Economic Moat
Yswm
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if 01244 is a good fit for your portfolio.

Trading Information

Previous Close Price
HKD 6.30
Day Range
HKD 5.846.43
52-Week Range
HKD 4.68131.50
Bid/Ask
HKD 5.93 / HKD 6.03
Market Cap
HKD 1.56 Bil
Volume/Avg
1.3 Mil / 1.1 Mil

Key Statistics

Price/Earnings (Normalized)
Price/Sales
0.36
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

3D Medicines Inc is a commercial-stage biopharmaceutical company that researches, develops, and commercialization of drugs in the field of managing cancer as a chronic disease. It develops differentiated immuno-oncology drugs, helping cancer patients live with prolonged survival time and quality of life.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Total Number of Employees
215

Comparables

Valuation

Metric
01244
06628
02171
Price/Earnings (Normalized)
Price/Book Value
1.700.731.53
Price/Sales
0.366.72
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
01244
06628
02171
Quick Ratio
2.541.506.57
Current Ratio
2.671.616.63
Interest Coverage
−148.04−33.53−111.54
Quick Ratio
01244
06628
02171

Profitability

Metric
01244
06628
02171
Return on Assets (Normalized)
−16.32%−19.81%−30.43%
Return on Equity (Normalized)
−24.03%−29.44%−35.82%
Return on Invested Capital (Normalized)
−20.28%−22.89%−34.73%
Return on Assets
01244
06628
02171
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRMsnvqgldqJxh$571.0 Bil
VRTX
Vertex Pharmaceuticals IncZqcmqbbHfzmyg$107.8 Bil
REGN
Regeneron Pharmaceuticals IncMjpxdkhzfGjxbz$106.1 Bil
MRNA
Moderna IncQqzmwhybdSlxs$42.3 Bil
ARGX
argenx SE ADRCcsfqkdcGmw$23.7 Bil
BNTX
BioNTech SE ADRHrrmpyrZwpq$22.1 Bil
ALNY
Alnylam Pharmaceuticals IncFbvtbqbbSdpgsnc$19.4 Bil
BMRN
Biomarin Pharmaceutical IncKmfmcgyhdZcpzsd$16.7 Bil
RPRX
Royalty Pharma PLC Class ASnvsqbhbsvNylwgrp$13.6 Bil
INCY
Incyte CorpKpghwjvVxdnwq$12.8 Bil

Sponsor Center